INTRODUCTION
Retinoic acid (RA), a metabolic derivative of vitamin A, plays a crucial role in the development and differentiation of the nervous system (1) . During normal embryogenesis, there is a requirement for precise timing of the exposure of embryonal structures to RA and a coordinated pattern of expression of the retinoic acid receptor (RAR) and retinoic acid X receptor (RXR) isoforms (2) . In addition, RA plays an important role in function of the adult brain, which has been shown to synthesize RA, and express retinoid receptors, as well cellular binding proteins (3) . Many studies on a variety of embroygenic neuronal cell types have shown that RA can stimulate both neurite number and length (4), and neurite outgrowth in amphibian spinal cord (5) . SH-SY5Y cells, a neuroblastic subclone of the neuroblastoma cell line SK-N-SH, withdraw from the cell cycle and exhibit a distinct neuronal phenotype when treated with different agents such as neurotrophic factors (6) , retinoic acid (6), phorbol ester (7), or staurosporine (8, 9) . The RA-induced change to a neuronal phenotype in SH-SY5Y cells is associated with increased expression of tissue-transglutaminase (TGase) (10) (11) (12) . TGase, a GTPbinding protein, participates in signal transduction pathways as a nonconventional G -protein, and exhibits distinct GTP-binding/hydrolyzing and transglutaminase activities (13) (14) (15) .
muscle and appears to function as a signal transducer during differentiation of myoblasts to myotubes (40) . However, its role in neuronal differentiation is not demonstrated.
There is growing evidence that RA-induced neuronal differentiation in SH-SY5Y cells is mediated by TGase. Using stable cell lines of SH-SY5Y, overexpressing wild type, C 277S mutant (transglutaminase defective), and anti-sense TGase, it has been demonstrated that TGase is necessary and sufficient in promoting neurite outgrowth (12) . However, the signaling mechanisms involved during differentiation, are not known. Here, we present evidence that RAinduced neuronal differentiation in SH-SY5Y cells is associated with increased expression/activation of TGase, leading to transamidation of RhoA. After transamidation, RhoA is activated and promotes formation of stress fibers and focal adhesion complexes. The transamidated RhoA also promotes activation of ERK1/2, and p38γ MAP kinase, which may regulate nuclear events for promoting gene expression during neuronal differentiation.
7 transferred to nitrocellulose membrane and exposed to Kodak X -ray film. Loading differences (between samples) were determined by blotting the membrane with anti-ERK, JNK1 or p38 α/β, -γ, -δ antibodies.
Immunoblotting. The expression level of TGase, neuronal marker growth-associated protein 43 (GAP-43), and neurofilament B (NF-B) were determined by immunoblotting. Cells were treated with or without RA in medium containing 10% FBS for the indicated times. After washing with cold PBS, the cells were harvested in lysis buffer containing 25mM Tris-HCl (pH 7.4), 100mM NaCl, 1mM EDTA, 1mMDTT, 1%Triton X -100, 1mM PMSF, 10µg/ml aprotinin and leupeptin. Insoluble material was removed by sedimentation at 10,000xg for 15 min at 4°C.
The protein concentration was determined according to the Bio-Rad method. Lysates (50 µg protein) were electrophoresed on SDS-PAGE, transferred to nitrocellulose membrane, blotted with anti-TGase, GAP-43, and NF-B antibody. The blots were reprobed with anti-actin antibody to determine the loading difference between samples. Scanning densitometry was used for semiquantitative analysis of the data.
Rhotekin-binding assay. RhoA activation was determined using the Rhotekin-binding assay, as previously described (43). In brief, cells were lysed with lysis buffer containing 50 mM Tris, pH 7.2, 1% Triton X-100, 0.5% sodium deoxycholate, 0.1% SDS, 500 mM NaCl, 10 mM MgCl 2 , 10 µg/ml each of leupeptin and aprotinin, and 1 mM PMSF. Analysis of cell morphology. To study the effect of RhoA, and MAPK pathways on RAinduced neurite outgrowth, SH-SY5Y cells were pretreated with C3 exoenzyme, monodansylcadaverine (MDC), PD98059 (specific MEK inhibitor), SB202190 (specific inhibitor of p38 MAPK), and JNK inhibitor or DMSO before addition of 5 µM RA in medium with 10% FBS. Medium with or without different inhibitors was replaced every day. After 4 days, the cell photographs were taken using a Nikon digital camera. The cell lysates were used for determining neuronal marker expression and transglutaminase activity.
Transglutaminase activity assay. Untreated and RA treated SH-SY5Y cells were lysed and 100 µg of protein from the lysate was used for the assay of transglutaminase activity, as previously described (13, 44) .
Transamidation reaction. SH-SY5Y cells, grown to 40% subconfluence in DMEM containing 3% FBS, were treated (or untreated) with 5 µM RA for 2 days. Labeling (in vivo) of [C-14] putrescine (0.5 µCi/ml) was performed overnight in the presence of aminoguanidine (100 mM), as described previously (15) . Cells were lysed and precipitated with RhoA antibody (or GST-RBD beads). Samples were subjected to SDS-PAGE (15%) and the gel was dried after incubating with a signal enhancer kit. Transamidated proteins were detected by autoradiography.
Statistical analysis. Data presented are mean ! SEM. Statistical differences were determined by a student's t-test for statistical significance (P<0.05).
RESULTS
RA promotes expression of TGase and neuronal markers. RA-induced cellular differentiation is coupled with increased expression/activation of TGase in many cell lines (12, 16) . To further study the role of TGase in RA-induced neuronal differentiation in SH-SY5Y cells, we determined the expression level of TGase and neuronal markers in response to RA treatment. As shown in Fig.1A and B, upregulation of TGase expression was observed after 1 day RA treatment, which was associated with increased transglutaminase activity (approx. 10-fold, specific activity-110 nmoles of putrescine incorporated/mg of casein/mg of protein, compared to 10.5 nmoles putrescine incorporated/mg of casein/mg of protein. (Fig. 1C ).
To examine whether transamidated RhoA is activated, the Rhotekin-binding assay was For studying the signaling events that are initiated by TGase in RA-induced neuronal differentiation, we have used MDC, which acts as a pseudo-substrate inhibitor of TGase, and is extensively used for inhibition of in vivo transamidation reactions (15, 49) . It competes with polyamines for transglutamination, and prevents their incorporation into proteins. MDC is toxic at higher doses and induces apoptosis in HL60 cells (400 µM for more than 4 days treatment)
and prevents the anti-apoptotic function of TGase at lower doses and shorter periods of treatment (16) . In SH-SY5Y cells, MDC dose-dependently inhibited RA-induced transglutaminase activity (Fig 3A) , and induced apoptosis when used at 200 µM (12h) in low serum (data not shown).
RhoA is an in vivo substrate of TGase, and it has been shown that RA treatment of Hela cells RA promoted activation of ERK1/2, JNK1 and p38γ in SH-SY5Y cells, which was inhibited by MDC, indicating that transglutaminase activity is involved in the activation ( (Fig 10) . Results are means ± SEM for four separate experiments (C). The bands corresponding to 32 P-MBP, 32 P-c-jun, and 32 P-ATF-2 were scanned by densitometry and analyzed by Image'Quant software. Results are means ± SEM for three separate experiments (B). 
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